Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Americium”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 127 records · Page 7Linked to original sources

Characterisation of the IRSN graphite moderated Americium-Beryllium neutron field.

The SIGMA facility was set up at IRSN to provide thermal neutrons for metrology and dosimetry purposes. SIGMA consists of six Am-Be radioactive sources located in a 1.5 x 1.5 x 1.5 m3 graphite moderator block. The neutron field at the calibration position, situated at 50 cm from the west surface of the assembly was characterised experimentally and by Monte Carlo calculations. The thermal neutron fluence was determined by the activation of gold foils; the neutron fluence energy distribution above 240 keV was measured with proton recoil spectrometers and the neutron fluence energy distribution from thermal energies to 20 MeV was measured with a Bonner spheres spectrometer. A Monte Carlo simulation of the SIGMA assembly was undertaken using the MCNP4C code, and the calculated neutron fluence energy distribution was compared with the measurements. As a whole, the experimental data and the MCNP calculation are in a good agreement.

Algorithms↗

Efficacy of orally administered amphipathic polyaminocarboxylic acid chelators for the removal of plutonium and americium: comparison with injected Zn-DTPA in the rat.

Chelators are used to promote excretion of actinides and some other metals, but few are orally effective. The relative efficacies of orally administered triethylenetetraminepentaacetic acids (TT) with varying lipophilic properties on the removal of 241Am and 239Pu and comparison with parenteral Zn-DTPA was determined. The actinides were administered to adult rats 2 weeks prior to initiation of 30 d of chelation treatment. The TT compounds were given orally while Zn-DTPA was given twice weekly by injection. Total body content of 241Am was measured before and during the treatment period and organ contents of 241Am and 239Pu were measured at the end of the study. Significant reductions in 241Am occurred within the first week, with Zn-DTPA being the most effective. By 3 weeks, the most lipophilic chelator, C22TT was as effective as Zn-DTPA. After 30 d, reductions in organ content of 239Pu and 241Am directly correlated with increasing lipophilicity of the TT chelators. Oral C22TT was as effective as injected Zn-DTPA in liver and bone, the major organs of actinide deposition. The removal of 239Pu from the liver and reduction of redeposition of 239Pu in newly formed bone by C22TT was confirmed by neutron-induced autoradiographs. The amphipathic TT chelators may be useful as orally administered alternatives to current parenteral DTPA for the removal of actinide elements from the body, particularly for longer-term therapeutic applications.

Acetates↗